AM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Antero Midstream (AM) is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has decent technical support and a mildly constructive trend, but the broader evidence is mixed: analysts are turning more favorable, yet hedge funds and insiders are actively selling, and there is no fresh news or financial-quarter detail to reinforce a high-conviction entry. Given the user is impatient and does not want to wait for a perfect entry, I would still not call this a buy today; the better call is hold and wait for stronger confirmation or a clearer pullback-to-support setup.
Price is 22.46 and trading above the pivot at 22.276, with resistance at 23.046 and 23.522 and support at 21.507 and 21.031. The moving averages are bullish (SMA_5 > SMA_20 > SMA_200), which supports an uptrend. MACD histogram is positive at 0.09, though it is contracting, so momentum is still positive but not accelerating. RSI_6 at 54.6 is neutral, showing neither overbought nor oversold conditions. Overall, the chart is mildly bullish, but not a strong breakout signal yet.
Morgan Stanley upgraded AM to Equal Weight from Underweight and raised the target to $26 from $20, which improves sentiment and suggests upside from current levels. The firm highlighted selective exposure to durable EBITDA growth in midstream infrastructure. Technicals remain constructive with bullish moving averages and positive MACD. The stock trend model also points to potential upside over the next month.
Hedge funds are selling aggressively, with selling up 532.39% over the last quarter, and insiders are also selling, up 269.17% over the last month. There is no recent news flow to drive a near-term catalyst. The MACD histogram is positive but contracting, which suggests momentum may be losing strength. Options volume shows short-term bearish hedging behavior despite the bullish open-interest profile.
Latest quarter financial snapshot data was unavailable due to an error, so there is no reliable quarter-by-quarter revenue, EBITDA, or EPS update to assess. Because the latest quarter season is not provided, I cannot confirm recent growth trends from earnings data.
Analyst sentiment has improved recently: Morgan Stanley upgraded AM to Equal Weight from Underweight and increased the price target to $26 from $20 on 2026-04-22. That indicates a more constructive Wall Street view than before. The pros view is that AM offers durable midstream EBITDA growth and dividend-supported total return potential. The cons view is that the stock is no longer clearly cheap, and the upgrade is only to Equal Weight rather than Overweight, so analysts are positive but not aggressively bullish.
